| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 07, 2023 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 972,814 | Jun 09, 2023, 05:12 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 07, 2023 | Sale | $9.05 | 56,436 | 510,808 | 916,378 | Jun 09, 2023, 05:12 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 15, 2023 | Tax Payment (Shares) | $5.60 | 11,661 | 65,302 | 941,564 | May 17, 2023, 06:16 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 03, 2023 | Sale | $4.92 | 1,000 | 4,915 | 0 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 03, 2023 | Conversion | - | 1,338 | - | 956,386 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2023 | Gift | - | 3,000 | - | 963,710 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 03, 2023 | Conversion | - | 4,000 | - | 4,000 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 03, 2023 | Gift | - | 10,000 | - | 955,048 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 02, 2023 | Conversion | - | 3,000 | - | 966,710 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 03, 2023 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 986,298 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 02, 2023 | Gift | - | 3,000 | - | 963,710 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 03, 2023 | Sale | $4.91 | 4,000 | 19,623 | 0 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 03, 2023 | Sale | $4.71 | 33,073 | 155,761 | 953,225 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 02, 2023 | Conversion | - | 3,000 | - | 966,710 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 03, 2023 | Conversion | - | 20,000 | - | 20,000 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 03, 2023 | Conversion | - | 1,000 | - | 1,000 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 02, 2023 | Gift | - | 3,000 | - | 963,710 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 03, 2023 | Sale | $4.90 | 20,000 | 98,036 | 0 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2023 | Conversion | - | 3,000 | - | 966,710 | May 05, 2023, 06:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2022 | Sale | $7.39 | 18,500 | 136,669 | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 19, 2022 | Gift | - | 3,000 | - | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 17, 2022 | Conversion | - | 3,000 | - | 585,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 19, 2022 | Gift | - | 12,000 | - | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 25, 2022 | Conversion | - | 12,000 | - | 594,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 16, 2022 | Conversion | - | 3,000 | - | 585,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 17, 2022 | Gift | - | 3,000 | - | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 21, 2022 | Conversion | - | 3,000 | - | 585,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 16, 2022 | Gift | - | 3,000 | - | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 25, 2022 | Gift | - | 12,000 | - | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 19, 2022 | Conversion | - | 3,000 | - | 585,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 21, 2022 | Gift | - | 3,000 | - | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 14, 2022 | Conversion | - | 3,000 | - | 585,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 12, 2022 | Conversion | - | 12,000 | - | 594,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 19, 2022 | Gift | - | 3,000 | - | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 19, 2022 | Conversion | - | 3,000 | - | 585,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 14, 2022 | Gift | - | 3,000 | - | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 12, 2022 | Gift | - | 12,000 | - | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2022 | Conversion | - | 18,500 | - | 601,305 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 19, 2022 | Conversion | - | 3,000 | - | 585,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 19, 2022 | Gift | - | 3,000 | - | 582,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 19, 2022 | Conversion | - | 12,000 | - | 594,805 | Apr 28, 2023, 04:32 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2023 | Gift | - | 10,000 | - | 928,787 | Apr 07, 2023, 05:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2023 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 960,037 | Apr 07, 2023, 05:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2023 | Sale | $6.46 | 13,327 | 86,038 | 946,710 | Apr 07, 2023, 05:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 06, 2023 | Sale | $6.64 | 40,000 | 265,672 | 906,710 | Apr 07, 2023, 05:30 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 13, 2023 | Conversion | - | 3,000 | - | 941,787 | Mar 15, 2023, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 13, 2023 | Gift | - | 3,000 | - | 938,787 | Mar 15, 2023, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 08, 2023 | Conversion | - | 20,000 | - | 20,000 | Mar 10, 2023, 05:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 08, 2023 | Sale | $8.10 | 70,890 | 573,925 | 963,787 | Mar 10, 2023, 05:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 08, 2023 | Sale | $8.10 | 20,000 | 161,900 | 0 | Mar 10, 2023, 05:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 08, 2023 | Conversion | - | 1,000 | - | 1,000 | Mar 10, 2023, 05:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 09, 2023 | Sale | $7.77 | 15,000 | 116,621 | 938,787 | Mar 10, 2023, 05:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 08, 2023 | Sale | $8.09 | 1,000 | 8,087 | 0 | Mar 10, 2023, 05:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 08, 2023 | Gift | - | 10,000 | - | 953,787 | Mar 10, 2023, 05:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 08, 2023 | Conversion | - | 4,000 | - | 4,000 | Mar 10, 2023, 05:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 08, 2023 | Option/RSU Exercise | $2.48 | 93,750 | 232,500 | 1,034,677 | Mar 10, 2023, 05:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 08, 2023 | Sale | $8.09 | 4,000 | 32,362 | 0 | Mar 10, 2023, 05:34 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 02, 2023 | Sale | $7.90 | 500 | 3,952 | 0 | Mar 06, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 02, 2023 | Conversion | - | 18,500 | - | 956,427 | Mar 06, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 02, 2023 | Conversion | - | 1,000 | - | 1,000 | Mar 06, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 02, 2023 | Sale | $7.92 | 18,500 | 146,502 | 940,927 | Mar 06, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 02, 2023 | Sale | $7.91 | 1,000 | 7,906 | 0 | Mar 06, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 02, 2023 | Conversion | - | 1,000 | - | 1,000 | Mar 06, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 02, 2023 | Sale | $7.91 | 1,000 | 7,909 | 0 | Mar 06, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 02, 2023 | Conversion | - | 500 | - | 500 | Mar 06, 2023, 06:07 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 15, 2023 | Tax Payment (Shares) | $8.44 | 1,346 | 11,360 | 940,927 | Feb 17, 2023, 05:14 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 02, 2023 | Sale | $9.20 | 1,000 | 9,202 | 0 | Feb 03, 2023, 05:11 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 02, 2023 | Conversion | - | 500 | - | 500 | Feb 03, 2023, 05:11 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 01, 2023 | Tax Payment (Shares) | $8.55 | 1,382 | 11,816 | 942,273 | Feb 03, 2023, 05:11 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 02, 2023 | Sale | $9.21 | 500 | 4,604 | 0 | Feb 03, 2023, 05:11 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 02, 2023 | Conversion | - | 18,500 | - | 960,773 | Feb 03, 2023, 05:11 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 02, 2023 | Conversion | - | 1,000 | - | 1,000 | Feb 03, 2023, 05:11 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 02, 2023 | Sale | $9.22 | 18,500 | 170,548 | 942,273 | Feb 03, 2023, 05:11 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 02, 2023 | Sale | $9.21 | 1,000 | 9,208 | 0 | Feb 03, 2023, 05:11 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 02, 2023 | Conversion | - | 1,000 | - | 1,000 | Feb 03, 2023, 05:11 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2023 | Sale | $7.39 | 18,500 | 136,669 | 525,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Sep 19, 2022 | Gift | - | 3,000 | - | 534,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 12, 2022 | Gift | - | 12,000 | - | 558,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2023 | Sale | $7.39 | 1,000 | 7,391 | 0 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2023 | Conversion | - | 1,000 | - | 1,000 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Oct 19, 2022 | Gift | - | 3,000 | - | 531,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | May 19, 2022 | Gift | - | 12,000 | - | 546,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2023 | Sale | $7.38 | 1,000 | 7,382 | 0 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 16, 2022 | Gift | - | 3,000 | - | 528,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jun 21, 2022 | Gift | - | 3,000 | - | 543,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2023 | Conversion | - | 500 | - | 500 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 14, 2022 | Gift | - | 3,000 | - | 525,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jul 19, 2022 | Gift | - | 3,000 | - | 540,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2023 | Sale | $7.38 | 500 | 3,689 | 0 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2023 | Conversion | - | 18,500 | - | 544,305 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Aug 17, 2022 | Gift | - | 3,000 | - | 537,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 25, 2022 | Gift | - | 12,000 | - | 570,805 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 05, 2023 | Conversion | - | 1,000 | - | 1,000 | Jan 06, 2023, 06:28 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 01, 2022 | Sale | $9.28 | 1,000 | 9,277 | 0 | Dec 02, 2022, 06:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 01, 2022 | Conversion | - | 500 | - | 500 | Dec 02, 2022, 06:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 01, 2022 | Conversion | - | 18,500 | - | 601,305 | Dec 02, 2022, 06:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 01, 2022 | Sale | $9.26 | 500 | 4,632 | 0 | Dec 02, 2022, 06:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 01, 2022 | Option/RSU Exercise | $2.48 | 31,250 | 77,500 | 601,515 | Dec 02, 2022, 06:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 01, 2022 | Conversion | - | 1,000 | - | 1,000 | Dec 02, 2022, 06:17 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 01, 2022 | Sale | $9.02 | 37,210 | 335,760 | 582,805 | Dec 02, 2022, 06:17 PM |
